Raj Mehra, PhD, and Krishna Subramanian, PhD, on Parkinson Disease Gene Therapy Mouse Studies
Mehra and Subramanian discussed preclinical safety studies with the gene therapy SLS-004 and plans for future research.
Raj Mehra, PhD, and Krishna Subramanian, PhD, on Striving For Disease-Modifying Therapies in Parkinson Disease
Mehra and Subramanian discussed preclinical research with the investigational gene therapy SLS-004.